Iovance Biotherapeutics, Inc. (FRA:2LB)
1.891
+0.035 (1.91%)
Last updated: Dec 4, 2025, 8:07 AM CET
-78.05% (1Y)
| Market Cap | 748.88M |
| Revenue (ttm) | 213.44M |
| Net Income (ttm) | -338.90M |
| Shares Out | n/a |
| EPS (ttm) | -1.02 |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | n/a |
| Average Volume | 762 |
| Open | 1.891 |
| Previous Close | 1.856 |
| Day's Range | 1.891 - 1.891 |
| 52-Week Range | 1.431 - 8.614 |
| Beta | n/a |
| RSI | 46.83 |
| Earnings Date | Feb 26, 2026 |